Study of the Possible Role of MicroRNA 106b in Psoriasis Vulgaris | ||||
| Benha Journal of Applied Sciences | ||||
| Article 23, Volume 9, Issue 2, February 2024, Page 167-172 PDF (462.17 K) | ||||
| Document Type: Original Research Papers | ||||
| DOI: 10.21608/bjas.2024.268020.1318 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Heba Elsayed Abd Elraheem  1; nancy wadie2; Mahmoud Tawfick3; Aliaa Mohamed4
| ||||
| 1Department of Dermatology, Venerology and Andrology Faculty of Medicine - Benha University | ||||
| 2Professor of Dermatology, Venerology and Andrology Faculty of Medicine - Benha University | ||||
| 3Professor of Microbiology and Immunology Faculty of Pharmacy, Al-Azhar University, Cairo | ||||
| 4Lecturer of Dermatology,Venerology and Andrology Faculty of Medicine - Benha University | ||||
| Abstract | ||||
| Abstract Objectives: Investigating the role of the serum level of MicroRNA106b in psoriatic patients and its relation to disease severity.Background: MicroRNA106b has been shown to play a crucial role in the pathogenesis of several autoimmune diseases but was poorly investigated in patients with psoriasis.Data Sources: By searching and reviewing Medline databases (Pub Med and Medscape) and looking for studies that examined the possible role of MicroRNA106b in patients with psoriasis available till 2022. Study Selection: All studies were independently assessed for inclusion. They were included if they fulfilled the following criteria: 1.Written and published in English language. 2. Published in peer-reviewed journals. 3.Explain how the level of serum MicroRNA106b may be linked to psoriasis vulgaris.Data Extraction: If the studies did not fulfill the inclusion criteria, they were excluded. Study quality assessment factors included whether ethical approval was gained, eligibility criteria specified, appropriate controls, and adequate information and well-defined evaluation measures. Data from each eligible study were independently abstracted using a data collection form to capture information related to our concerned study outcomes. Conclusions: Serum MicroRNA106b level is lower in patients with psoriasis vulgaris. | ||||
| Keywords | ||||
| Psoriasis Vulgaris; MicroRNAs | ||||
|
Supplementary Files
|
||||
|
Statistics Article View: 28 PDF Download: 48 |
||||
